Skip to content

Enhanced bronchoscopic airway mucus clearance in patients with AECOPD after receiving a single high-frequency chest wall oscillation: A randomized controlled study

Enhanced bronchoscopic airway mucus clearance in patients with AECOPD after receiving a single high-frequency chest wall oscillation: A randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079458
Enrollment
Unknown
Registered
2024-01-03
Start date
2024-01-03
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Experimental group:On the basis of routine care, high-frequency chest wall concussion treatment was given. After treatment, patients were instructed to cough effectively according to routine, except f
Control group:Preoperative, intraoperative, and postoperative care was routine according to electronic bronchoscopy, including effective cough instruction 10 minutes before surgery, except for subject

Sponsors

Meizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Age =40 years ?Diagnosed (including previously diagnosed) COPD, AECOPD is defined as an acute exacerbation of symptoms such as cough, sputum, and shortness of breath, resulting in the need for additional treatment ? Electronic bronchoscopy is required for clinical diagnosis and treatment, and there are no contraindications for electronic bronchoscopy ? Informed consent and voluntary participation in this study

Exclusion criteria

Exclusion criteria: ?Combined with other respiratory diseases, such as lung cancer, tuberculosis, interstitial pneumonia, etc ? The patient had received high-frequency chest wall oscillations within three days ? The head or neck injury has not been stabilized ? The patients considered by the investigators to be unsuitable for participating in this study

Design outcomes

Primary

MeasureTime frame
bronchoscopy-identified luminal mucus score,LMS;

Secondary

MeasureTime frame
The amount of voluntary sputum produced;The amount of mucus collected by bronchoscope;Etiological positive rate of alveolar lavage fluid;The incidence of adverse events;

Countries

China

Contacts

Public ContactLing ZHONG

Meizhou People's Hospital

927524743@qq.com+86 135 6099 7686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026